Your browser doesn't support javascript.
loading
Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance.
Park, Mirae; Lalvani, Ajit; Satta, Giovanni; Kon, Onn Min.
Afiliação
  • Park M; Department of Respiratory Medicine, Imperial College Healthcare NHS Trust, St Mary's Hospital, Praed Street, London, UK.
  • Lalvani A; National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, SW3 6LY, UK.
  • Satta G; Tuberculosis Research Centre, National Heart and Lung Institute, Imperial College London, Norfolk Place, London, W2 1PG, UK.
  • Kon OM; Department of Infectious Diseases, Imperial College Healthcare NHS Trust, St Mary's Hospital, Praed Street, London, W2 1NY, UK.
BMC Infect Dis ; 22(1): 349, 2022 Apr 07.
Article em En | MEDLINE | ID: mdl-35392842
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Mycobacterium tuberculosis Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Mycobacterium tuberculosis Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido